Wednesday, 29 October 2014

Facilitating global development of biosimilars

EMA to allow use of non-EEA authorised comparator in clinical studies (European Medicines Agency)

Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial

The early manifestation of diabetes complications in youth-onset T2DM suggests that this group will be burdened with the tangible consequences of cardiovascular disease, nephropathy, and retinopathy in the third and fourth decades of life (Diabetes and Its Complications)

No comments:

Post a Comment